2015
DOI: 10.1177/1932296815609371
|View full text |Cite
|
Sign up to set email alerts
|

Incorporating an Exercise Detection, Grading, and Hormone Dosing Algorithm Into the Artificial Pancreas Using Accelerometry and Heart Rate

Abstract: In this article, we present several important contributions necessary for enabling an artificial endocrine pancreas (AP) system to better respond to exercise events. First, we show how exercise can be automatically detected using body-worn accelerometer and heart rate sensors. During a 22 hour overnight inpatient study, 13 subjects with type 1 diabetes wearing a Zephyr accelerometer and heart rate monitor underwent 45 minutes of mild aerobic treadmill exercise while controlling their glucose levels using senso… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
72
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 92 publications
(76 citation statements)
references
References 29 publications
(54 reference statements)
3
72
0
1
Order By: Relevance
“…Few patients achieve this even with intensive insulin treatment [1]. New approaches with automatic glucose controlled insulin and glucagon delivery, known as a dual-hormone artificial pancreas (AP), may offer a solution to improve glycemic control [2][3][4][5][6]. To design and tune control algorithms for AP devices prior to in vivo tests, a validated simulation model capturing the dynamics between glucose, insulin and glucagon is needed to perform helpful in silico experiments [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Few patients achieve this even with intensive insulin treatment [1]. New approaches with automatic glucose controlled insulin and glucagon delivery, known as a dual-hormone artificial pancreas (AP), may offer a solution to improve glycemic control [2][3][4][5][6]. To design and tune control algorithms for AP devices prior to in vivo tests, a validated simulation model capturing the dynamics between glucose, insulin and glucagon is needed to perform helpful in silico experiments [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…Several approaches have been investigated for the management of exercise during the operation of the single-hormone artificial pancreas [18][19][20][21][22]. A fully reactive system that is driven by glucose sensor data alone fails to prevent exerciseinduced hypoglycaemia, particularly because the delay in insulin absorption reduces the effectiveness of its suspension after the start of exercise [21].…”
Section: Introductionmentioning
confidence: 99%
“…A fully reactive system that is driven by glucose sensor data alone fails to prevent exerciseinduced hypoglycaemia, particularly because the delay in insulin absorption reduces the effectiveness of its suspension after the start of exercise [21]. The addition of a heart rate or activity sensor to the single-hormone artificial pancreas might reduce the risk of hypoglycaemia, although at the expense of an increased burden for the patient (via wearing multiple sensors) [22]. The use of glucagon in the dual-hormone artificial pancreas might be particularly beneficial during exercise, but limited data exist to quantify the additional benefits compared with the single-hormone artificial pancreas.…”
Section: Introductionmentioning
confidence: 99%
“…The glucose information along with additional types of information from accelerometers, and other sensors can be combined to deliver a recommended insulin infusion rate that can change almost continuously in response to changes in the metabolic milieu. 28 In such a system, it is necessary for decisions to be made locally with a processor located either worn by or carried by the patient (or somehow in the vicinity of the patient at all times) rather than by a cloud-based server which is going to suffer from potential delays in processing or temporary data dropout in case of data transmission problems. 29 Artificial pancreas systems in use and under development all use fog or edge computing systems.…”
Section: Diabetes Devices Currently Using Fog Computingmentioning
confidence: 99%